Dr. Darren C Mcauley DO

Recommended Articles

• Woman with Multiple Sclerosis Finds Relief in Stem Cell Therapy

  Karen Boyd, a 46-year-old woman from Traverse City, has been coping with multiple sclerosis (MS) for over 11 years. “It's where your own immune system attacks itself” she said. Boyd was first diagnosed in 2005, when she started taking several medications to help alleviate her symptoms. “I was...

• The Link Between Alzheimer’s Disease and Obesity

  Obesity has become a worldwide phenomenon. Statistics show that a third of the world’s population is either obese or overweight. Ranked with the most number of obese people, US, China, India, Russia, and Brazil top the list. But, what does this list really tell people? It’s simple—too much...

• Low Adherence to Antidepressants May Increase Mortality in Parkinson's Patients

  Parkinson’s disease, a neurological condition that affects a person’s body movements,  has been affecting thousands of people’s physical and mental abilities. According to the National Parkinson Foundation, Parkinson’s disease itself is not fatal. However, complications that are brought by...

• Targeting Enzyme May Be an Approach to Alzheimer’s Therapy

  Targeting particular enzymes to cure diseases or to relieve symptoms has never been an easy task. Indiscriminate targeting often results in unnecessary potentially toxic effects. For the same reasons, early attempts to target HDAC2 were not successful.Researchers knew that HDAC2 plays a vital role...

• Understanding the Relationship Between Constipation and Parkinson’s

  As technology progresses, understanding about the intensive dialogue between the gut and the brain is also getting better. It is now understood that if things go wrong with this exchange, it is terrible for both of them. Changes in the activity of the gut may worsen the functioning of the brain,...

• Diabetes Drug May Help Prevent Parkinson's, Study Shows

  Drugs used to treat type 2 diabetes, belonging to a class called glitazones (GTZs) may reduce the risk of Parkinson’s by as much as 28 percent, a study suggests. It was a large scale study done by analyzing more than 100 million prescriptions. ...